CAMBRIDGE, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corp., a clinical-stage biotechnology company harnessing the power of regulatory RNA to restore healthy gene expression, today ...
An Indiana University School of Medicine physician scientist is making strides in understanding the molecular origins of fatty liver disease, a leading cause of liver failure in the United States. By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback